Quick Search:       Advanced Search
Chinese Version 
Online office
Journal Online
Download
Top
Links

扫描微信二维码,获取更多信息
Mechanism of Chaihu Shugan Powder (柴胡疏肝散) for Treating Depression Based on Network Pharmacology
  
View Full Text  View/Add Comment  Download reader
KeyWord:network pharmacology, Chinese medicine, Chaihu Shugan Powder, target, pathway, depression
Author NameAffiliationE-mail
LIU Yuan-yue,HU Dan,FAN Qi-qi   
SHENG Lei Department of Neurology, Jiangsu Provincial Second Chinese Medicine Hospital, The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing(210017), China hejieqong1234@163.com 
Hits: 572
Download times: 0
Abstract:
      Objective: To analyze the effective components of Chinese medicine (CM) contained in Chaihu Shugan Powder (柴胡疏肝散, CSP) in the treatment of depressive disorders and to predict its anti-depressant mechanism by network pharmacology. Methods: Absorption, distribution, metabolism, excretion, and toxicity calculation method was used to screen the active components of CSP. Traditional Chinese Medicine System Pharmacological Database Analysis Platform and text mining tool (GoPuMed database) were used to predict and screen the active ingredients of CSP and anti-depressive targets. Through Genetic Association Database, Therapeutic Target Database, and PharmGkb database targets for depression were obtained. Cytoscape3.2.1 software was used to establish a network map of the active ingredients-targets of CSP, and to analyze gene function and metabolic pathways through Database for Annotation, Visualization and Integrated Discovery and the Omicshare database. Results: The 121 active ingredients and 15 depression-related targets which were screened from the database can exert antidepressant effects by improving the neural plasticity, growth, transfer condition and gene expression of neuronal cell, and the raise of the expression of gap junction protein. The 15 targets passed 14 metabolic pathways, mainly involved in the regulation of neurotransmitters (5-hydroxytryptamine, dopamine and epinephrine), inflammatory mediator regulation of TRP channels, calcium signaling pathway, cyclic adenosine monophosphate signaling pathway and neuroactive ligand-receptor interaction and other signal channels to exert anti-depressant effects. Conclusion: This article reveals the possible mechanism of CSP in the treatment of depression through network pharmacology research, and lays a foundation for further target studies.
Close